Epidemiological studies of CHD and the evolution of preventive cardiology (Q34411784)

2 August 2017

title

Epidemiological studies of CHD and the evolution of preventive cardiology (English)

1 reference

2 August 2017

1 reference

Nathan D Wong

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

25 March 2014

1 reference

Nature Reviews Cardiology

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

276-289

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

CORONARY HEART DISEASE AMONG MINNESOTA BUSINESS AND PROFESSIONAL MEN FOLLOWED FIFTEEN YEARS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Cardiovascular disease epidemiology: a journey from the past into the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Legacy of the framingham heart study: rationale, design, initial findings, and implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Epidemiological approaches to heart disease: the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Coronary heart disease in the Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Diabetes and cardiovascular disease. The Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Genome-wide association study of blood pressure and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Natural History of Congestive Heart Failure: The Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Prediction of Coronary Heart Disease Using Risk Factor Categories

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Sixty years of preventive cardiology: a Framingham perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Trends in coronary risk factors in the WHO MONICA project.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

A "natural experiment" in cardiovascular epidemiology in the early 21st century

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Myocardial ischaemia, risk factors and death from coronary heart-disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Plasma cholesterol concentration and mortality. The Whitehall Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Health inequalities among British civil servants: the Whitehall II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Justice at work and reduced risk of coronary heart disease among employees: the Whitehall II Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

CARDIA: study design, recruitment, and some characteristics of the examined subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Echocardiographic Design of a Multicenter Investigation of Free-living Elderly Subjects: The Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Changes in risk factors for cardiovascular disease by baseline weight status in young adults who maintain or gain weight over 15 years: the CARDIA study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Racial differences in incident heart failure among young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Cardiovascular Health Study: design and rationale

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the jackson heart study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Multi-Ethnic Study of Atherosclerosis: objectives and design

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Coronary artery calcium score and risk classification for coronary heart disease prediction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Design and implementation of the Hispanic Community Health Study/Study of Latinos

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

C-reactive protein, fibrinogen, and cardiovascular disease prediction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Diabetes mellitus, fasting glucose, and risk of cause-specific death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Association between 9p21 genomic markers and heart disease: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Genetic predisposition to higher blood pressure increases coronary artery disease risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Discovery and refinement of loci associated with lipid levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Statins for people at low risk of cardiovascular disease – Authors' reply

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

A general cardiovascular risk profile: The Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Predicting the 30-year risk of cardiovascular disease: the framingham heart study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Lifetime risk of developing coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Lifetime risks of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Coronary heart disease epidemiology revisited. Clinical and community aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Public policy approaches to the prevention of heart disease and stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Physical activity and risk of cardiovascular disease--a meta-analysis of prospective cohort studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Social class differences in ischaemic heart disease in British men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The Nurses' Health Study: 20-year contribution to the understanding of health among women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

A randomized trial of aspirin and beta-carotene among U.S. physicians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

Design of the Women’s Health Initiative Clinical Trial and Observational Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCARDIO.2014.26

A north-south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report from the PRC-USA Collaborative Study of Cardiovascular Epidemiology

31 March 2020

1 reference

12 December 2020

The Stockholm prospective study. 1. The initial values for plasma lipids.

1 reference

12 December 2020

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

12 December 2020

Coronary heart disease in the Western collaborative group study. A follow-up experience of two years

1 reference

12 December 2020

1 reference

12 December 2020

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

12 December 2020

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

12 December 2020

Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study

1 reference

12 December 2020

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

1 reference

12 December 2020

The Tromsø Heart Study: family approach to intervention on CHD. Feasibility of risk factor reduction in high-risk persons--project description

1 reference

12 December 2020

Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study

1 reference

12 December 2020

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Atherosclerosis: a problem in newer public health

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2014.26

1 reference

Dimensions Publication ID

2 August 2017

1015087821

0 references

1 reference